An evidence-based guideline to help healthcare professionals give sound advice regarding mental health to people with cancer is sorely needed. Although there has been scarce clinical guidance, many healthcare professionals (HCPs) have been using...
Oncology / Hematology
RELEVANT ARTICLES IN Oncology / Hematology
Cumulative Radiation Dose From CT in Young People Linked to Malignancy Risk
Cumulative Radiation Dose From CT in Young People Linked to Malignancy Risk
TUESDAY, Nov. 28, 2023 (HealthDay News) -- Cumulative radiation dose to the bone marrow as a result of computed tomography (CT) examinations in individuals aged younger than 22 years is associated with an increased risk for subsequent hematological malignancies,...
Recent Decline in Risk for CRC Recurrence Seen in Stage I to III Disease
Recent Decline in Risk for CRC Recurrence Seen in Stage I to III Disease
TUESDAY, Nov. 28, 2023 (HealthDay News) -- From 2004 to 2019, the risk for recurrence of colorectal cancer (CRC) decreased in patients with stages I to III disease, according to a study published online Nov. 16 in JAMA Oncology to coincide with the annual meeting...
Advertisement
Neratinib, Fulvestrant, Trastuzumab Combo Aids Metastatic Breast Cancer
Neratinib, Fulvestrant, Trastuzumab Combo Aids Metastatic Breast Cancer
TUESDAY, Nov. 28, 2023 (HealthDay News) -- For patients with hormone receptor (HR)-positive HER2-mutant metastatic breast cancer (MBC) with progression on cyclin-dependent kinase 4/6 inhibitor (CDK4/6i) therapy, neratinib + fulvestrant + trastuzumab (N + F + T) is...
Subcutaneous Rituximab for NHL: Assessing Clinical Effectiveness and Safety
Subcutaneous Rituximab for NHL: Assessing Clinical Effectiveness and Safety
The following is a summary of “Clinical efficacy and safety of subcutaneous rituximab in non-Hodgkin lymphoma: a systematic literature review and meta-analysis,” published in the November 2023 issue of Hematology by Si et al. The efficacy and safety of subcutaneous...
Comprehensive Genomic DNA-Based Monitoring of MRD in Pediatric AML
Comprehensive Genomic DNA-Based Monitoring of MRD in Pediatric AML
The following is a summary of “Genomic DNA-based measurable residual disease monitoring in pediatric acute myeloid leukemia: unselected consecutive cohort study,” published in the November 2023 issue of Oncology by Zaliova et al. Monitoring measurable residual...
Cumulative Radiation Dose From CT in Young People Linked to Malignancy Risk
Cumulative Radiation Dose From CT in Young People Linked to Malignancy Risk
TUESDAY, Nov. 28, 2023 (HealthDay News) -- Cumulative radiation dose to the bone marrow as a result of computed tomography (CT) examinations in individuals aged younger than 22 years is associated with an increased risk for subsequent hematological malignancies,...
Recent Decline in Risk for CRC Recurrence Seen in Stage I to III Disease
Recent Decline in Risk for CRC Recurrence Seen in Stage I to III Disease
TUESDAY, Nov. 28, 2023 (HealthDay News) -- From 2004 to 2019, the risk for recurrence of colorectal cancer (CRC) decreased in patients with stages I to III disease, according to a study published online Nov. 16 in JAMA Oncology to coincide with the annual meeting...
Neratinib, Fulvestrant, Trastuzumab Combo Aids Metastatic Breast Cancer
Neratinib, Fulvestrant, Trastuzumab Combo Aids Metastatic Breast Cancer
TUESDAY, Nov. 28, 2023 (HealthDay News) -- For patients with hormone receptor (HR)-positive HER2-mutant metastatic breast cancer (MBC) with progression on cyclin-dependent kinase 4/6 inhibitor (CDK4/6i) therapy, neratinib + fulvestrant + trastuzumab (N + F + T) is...
Subcutaneous Rituximab for NHL: Assessing Clinical Effectiveness and Safety
Subcutaneous Rituximab for NHL: Assessing Clinical Effectiveness and Safety
The following is a summary of “Clinical efficacy and safety of subcutaneous rituximab in non-Hodgkin lymphoma: a systematic literature review and meta-analysis,” published in the November 2023 issue of Hematology by Si et al. The efficacy and safety of subcutaneous...
Comprehensive Genomic DNA-Based Monitoring of MRD in Pediatric AML
Comprehensive Genomic DNA-Based Monitoring of MRD in Pediatric AML
The following is a summary of “Genomic DNA-based measurable residual disease monitoring in pediatric acute myeloid leukemia: unselected consecutive cohort study,” published in the November 2023 issue of Oncology by Zaliova et al. Monitoring measurable residual...
Advertisement
CONDITION SPOTLIGHTS
ADVERTISEMENT
Protecting Peer Review Committees
Protecting Peer Review Committees
The doctors who serve on peer review committees must speak and act freely without fear of retaliation, therefore members often receive legal protections.
Medical Fiction: Stacey & the Perfect Spring Evening
Medical Fiction: Stacey & the Perfect Spring Evening
This is one of a collection of stories that are like “Final Destination” meets “The Monkey’s Paw” (W. W. Jacobs, 1902). As such, they are tragedies more than either mysteries or horror, and would appeal most to readers who enjoy the inexorable pull of a story arc...
Medical Fiction: Winnie & Her Miraculous Wheels
Medical Fiction: Winnie & Her Miraculous Wheels
This is one of a collection of stories that are like “Final Destination” meets “The Monkey’s Paw” (W. W. Jacobs, 1902). As such, they are tragedies more than either mysteries or horror, and would appeal most to readers who enjoy the inexorable pull of a story arc...
PW PODCAST
Advertisement
MORE STORIES IN Oncology / Hematology
FILTER ARTICLES BY:
Advertisement
PW PODCAST
CARTOONS
Thanksgiving Nerves
Thanksgiving Nerves
“I don’t know why Doc, but I always feel anxious around Thanksgiving!”
BUSINESS OF MEDICINE
Why Socially Responsible Investing May Be a Good Fit for Physicians
Why Socially Responsible Investing May Be a Good Fit for Physicians
Environmental, social, and governance (ESG) investing urges corporations to function in an ethically responsible manner, and interest is growing in this area.
How to Say “No” to Patients & Maintain a Solid Relationship
How to Say “No” to Patients & Maintain a Solid Relationship
Physicians must remember they took an oath to “do no harm” and must act in accordance with it, even if their choices do not meet a patient’s preferences.
How Physicians Can Engage in Social Media Use Without Inviting a Malpractice Suit
How Physicians Can Engage in Social Media Use Without Inviting a Malpractice Suit
Maintaining the utmost professionalism on social media apps is essential for physicians.
ADVERTISEMENT
Stay connected to the latest news with Physician’s Weekly
Insights from the leaders in medical research, trending topics in clinical medicine, and perspectives from your colleagues.
Subscribe to our free Newsletters to receive weekly emails, and even get a laugh or two from our medical cartoons.